Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Phase 3
This trial is looking at lenalidomide (Revlimid) as treatment for B cell chronic lymphocytic leukaemia (B cell CLL) in elderly people. This trial is open to people with B cell CLL aged 65 years or older.
Doctors often treat B cell CLL with chlorambucil, which is a chemotherapy drug. This trial is looking at comparing chlorambucil with lenalidomide.
Lenalidomide is a biological therapy. It mainly works by helping the body’s immune system target cancer cells.
The aims of this trial are to compare lenalidomide with chlorambucil to treat elderly people with B cell CLL.
Recruitment start: 11 November 2009
Recruitment end: 20 February 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Oscier
Celgene Corporation
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 27 Feb 2013
CRUK internal database number: 7874
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
